Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotechnology and Pharmaceuticals Breast cancer Bristol Myers Squibb business Cancer Clinical trial Conditions and Diseases Deal Eli Lilly European Commission European Union FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Margaret Hamburg Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News- Medicago Awarded $21 million from the US Department of Defense
- Regulators, Industry Disagree Over Noncritical Process Parameters at CMC Forum
- RecipharmCobra Biologics Receives Patent for Antibiotic-Free Plasmid Maintenance System
- President's Council and HHS Call for Overhaul of Pandemic Response Programs
- Nabi Receives Key Patent for Nicotine Vaccines, Enters Manufacturing Agreement with Diosynth
Clinical Trials NewsBlogroll
-
Meta
Tag Archives: Search
Live from DIA: FDA Warning Letters Stir More Questions Than Answers
A panel of regulators from FDA’s Division of Drug Marketing, Advertising, and Communications were taken to task, this morning at the Drug Information Association’s annual meeting, for 14 warning letters levied on drug companies for not including risk information in online search ads.
A Sanofi Aventis employee complained about the 14 warning letters and asked why [...]
Posted in Advertising, Regulatory Also tagged DDMAC, DIA, FDA, Marketing, new media, Warning Letters 1 Comment

Google Unveils New Pharma Ads